Elusys Therapeutics Inc
Elusys Therapeutics Inc is a federal award recipient based in Parsippany, NJ. The organization has received $55,273,060 in total federal obligations across 2 awards. Their primary industry classification is NAICS 325412.
Competitors in NAICS 325412
Other top federal contractors classified under the same primary NAICS code.
| Contractor | Location | Total Obligated |
|---|---|---|
| Mckesson Corporation | Irving, TX | $11.9B |
| Merck Sharp & Dohme LLC | Rahway, NJ | $2.9B |
| Pfizer Inc | New YORK, NY | $699.8M |
| Emergent Biosolutions Canada Inc | Winnipeg | $114.3M |
| Amgen USA Inc | Thousand OAKS, CA | $89.9M |
| Exelan Pharmaceuticals Inc | BOCA Raton, FL | $74.8M |
| Mckesson Specialty Distribution LLC | Memphis, TN | $61.5M |
| Seqirus USA Inc | Summit, NJ | $60.5M |
-
How much has Elusys Therapeutics Inc received in federal contracts?
Elusys Therapeutics Inc has received $55,273,060 in total federal contract obligations across 2 awards since 2000.
-
Which agencies work with Elusys Therapeutics Inc?
Elusys Therapeutics Inc works with 0 federal agencies. Their largest customer is N/A.
-
Is Elusys Therapeutics Inc a small business?
Elusys Therapeutics Inc does not currently hold small business certifications in the SAM.gov database.
-
What is Elusys Therapeutics Inc's UEI number?
Elusys Therapeutics Inc's Unique Entity Identifier (UEI) is ELP1DCK8L191 and their CAGE code is 1WEK8.
Data sourced from USASpending.gov and SAM.gov . Federal contracting data is public domain.